Cipla patents expiration
1. Argatroban In Sodium Chloride patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7687516 | CIPLA | Alcohol free formulation of argatroban |
Sep, 2027
(3 years from now) | |
| US7589106 | CIPLA | Alcohol free formulation of argatroban |
Sep, 2027
(3 years from now) | |
Drugs and Companies using ARGATROBAN ingredient
Market Authorisation Date: 29 June, 2011
Treatment: Method of treating an argatroban treatable condition; Method of treating thrombosis
Dosage: INJECTABLE;INTRAVENOUS
How can I launch a generic of ARGATROBAN IN SODIUM CHLORIDE before it's drug patent expiration?
More Information on Dosage
ARGATROBAN IN SODIUM CHLORIDE family patents
